di Pomezia: «Test also in Africa»
Pomezia - The words of Piero Di Lorenzo, president of IRBM: «At the end of June we will have the results of phase 1 of the experimentation»
For several days now, we have had a certainty: the Coronavirus vaccine candidate produced by the Irbm of Pomezia together with the University of Oxford has been the most advanced in the world. A news that makes the territory south of Rome proud, but also opens up interesting scenarios for the fight against the pandemic. For this reason, we asked some questions to Piero Di Lorenzo, president of Irbm, just to find out where the experimentation is and if the future vaccine can actually be produced in Pomezia.
The experimentation of the vaccine candidate that Irbm and the University of Oxford are working on has started a few months ago: what level have we reached? Are there any early results compared to the tests performed?
Experimental phase 3 tests are currently underway in England and Brazil on 10,000 volunteers. In order to prevent the drop in the number of infected people in European countries from calling into question the implementation of phase 3 and to give greater reliability to clinical tests, similar tests are starting in South Africa and Zaire. The results of phase 1 will be published at the end of June; Phase 3 is expected at the end of September